Speaker illustration

Doctor Josephine Harrington

Duke Clinical Research Institute, Durham (United States of America)

Member of:

European Society of Cardiology

Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence

Event: ESC Congress 2022

Topic: Anticoagulants

Session: How to balance efficacy and safety of anticoagulant therapy in clinical practice

Thumbnail

This platform is supported by

logo Novo Nordisk